{"id":"W2568364351","doi":"10.5489/cuaj.4294","title":"The next 10 years: Challenges for the future and overcoming resistance to targeted therapies for renal cell carcinoma","year":2016,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Targeted therapy; Cabozantinib; PI3K/AKT/mTOR pathway; Oncology; Discovery and development of mTOR inhibitors; Tyrosine kinase; Adjuvant; Internal medicine; Acquired resistance; Cancer research; Intensive care medicine; Cancer; Receptor; Signal transduction; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00102485,0.0005570977,0.001375092,0.00196303,0.0003916335,0.001330227,0.0008182583,0.001502813,0.003092748],"category_scores_gemma":[0.001503816,0.0002126999,0.0005380192,0.002043178,0.0006198088,0.002529597,0.0007441342,0.002268358,0.001005344],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009041753,"about_ca_system_score_gemma":0.002119896,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00290562,"about_ca_topic_score_gemma":0.008314269,"domain_scores_codex":[0.9997098,0.00006665144,0.00004935427,0.0000297866,0.0001182239,0.00002624655],"domain_scores_gemma":[0.9992812,0.0003376332,0.000101817,0.00001327147,0.0002055615,0.00006040345],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006434493,0.0000484452,0.0001625918,0.02139331,0.00008729497,0.0001991537,0.0001459799,0.00026898,0.00061122,0.005263574,0.05105776,0.9206973],"study_design_scores_gemma":[0.00001213331,0.00004919124,0.0005922001,0.008249653,0.0000925221,0.0009777725,0.0001899359,0.00006173324,0.0001144918,0.002328792,0.9873144,0.00001707297],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000414342,0.9989422,0.00002607532,0.0006193679,0.0001108581,0.000001099753,0.000005026108,0.000002163232,0.0002518132],"genre_scores_gemma":[0.0003810356,0.9988472,0.00006728914,0.0003353767,0.0001414294,0.000001856767,0.000007701135,7.270343e-7,0.000217264],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003092748,"threshold_uncertainty_score":0.01034623,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04543506718884423,"score_gpt":0.2706050532972803,"score_spread":0.2251699861084361,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}